INS and gestational diabetes: Basal insulin as a part of the GDM treatment was independently associated with pre-pregnancy BMI (adjOR 1.09; CI 1.03–1.16) and ‘unfavorable work conditions’ (adjOR 2.85; CI 1.33–6.11).